Literature DB >> 31164003

High-Power (40-50 W) Radiofrequency Ablation Guided by Unipolar Signal Modification for Pulmonary Vein Isolation: Experimental Findings and Clinical Results.

Thomas Pambrun1, Cyril Durand2, Marion Constantin1, Alexandre Masse3, Céline Marra3, Valentin Meillet3, Michel Haïssaguerre1, Pierre Jaïs1, Agustín Bortone4.   

Abstract

Background Although proposed to facilitate pulmonary vein isolation (PVI), high-power ablation may favor extracardiac damage. Negative component abolition of the unipolar signal reflects lesion transmurality. The present study sought to evaluate the safety and efficacy of high-power ablation using unipolar signal modification as a local end point. Methods High power and standard power were compared in 4 swine and 100 consecutive patients referred for PVI. The first 50 patients were included in the control group (25-30 W) and the last 50 patients in the study group (40-50 W). Atrial radiofrequency applications were stopped 2 s (study group and swine) or 5 s (control group) after unipolar signal modification. Ventricular radiofrequency applications of 500 J (25 W·20 s versus 50 W·10 s) were performed at the swine epicardium. Results Swine gross necropsy did not show any extracardiac damage related to atrial lesions. At equal energy of 500 J, 50 W lesions were deeper (3±0.9 versus 2.6±1.1 mm; P=0.03) and wider (6.2±2 versus 5±2.3 mm; P=0.006) than 25 W lesions. No complications occurred during the clinical study, whatever the power output used for PVI. For a similar sinus rhythm maintenance at 12 months (90% versus 88%; P=0.75), the study group displayed higher first-pass PVI (92% versus 73%; P<0.001), lower acute pulmonary vein reconnection (2% versus 17%; P<0.001), reduced procedure time (73.1±18.2 versus 107.4±21.2 min; P<0.001), and ablation time (13±2.9 versus 30.3±8.8 min; P<0.001). Conclusions High-power PVI guided by unipolar signal modification safely decreases procedural burden while ensuring robust 12-month outcomes.

Entities:  

Keywords:  atrial fibrillation; human; pulmonary vein; radiofrequency ablation; swine

Year:  2019        PMID: 31164003     DOI: 10.1161/CIRCEP.119.007304

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  16 in total

1.  Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.

Authors:  Dibbendhu Khanra; Abdul Hamid; Saurabh Deshpande; Anindya Mukherjee; Sanjiv Petkar; Mohammad Saeed; Indranill Basu-Ray
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

2.  Radiofrequency ablation data associated with atrioesophageal fistula.

Authors:  David R Tomlinson; John Mandrola
Journal:  HeartRhythm Case Rep       Date:  2021-12-15

Review 3.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

Review 4.  Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation.

Authors:  Xuerong Sun; Jiang Lu; Jinxuan Lin; Tianjie Feng; Ni Suo; Lihui Zheng; Zhimin Liu; Gang Chen; Xiaohan Fan; Shu Zhang; Guodong Niu
Journal:  Cardiol Res Pract       Date:  2021-02-15       Impact factor: 1.866

5.  The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta-analysis study.

Authors:  Yoga Waranugraha; Ardian Rizal; Achmad J Firdaus; Fransiska A Sihotang; Akita R Akbar; Defyna D Lestari; Muhammad Firdaus; Akhmad I Nurudinulloh
Journal:  J Arrhythm       Date:  2021-07-02

6.  Regional differences in the predictors of acute electrical reconnection following high-power pulmonary vein isolation for paroxysmal atrial fibrillation.

Authors:  Kyoichiro Yazaki; Koichiro Ejima; Shohei Kataoka; Miwa Kanai; Satoshi Higuchi; Daigo Yagishita; Morio Shoda; Nobuhisa Hagiwara
Journal:  J Arrhythm       Date:  2021-07-23

7.  Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.

Authors:  Xing Liu; Chun Gui; Weiming Wen; Yan He; Weiran Dai; Guoqiang Zhong
Journal:  J Interv Cardiol       Date:  2021-06-02       Impact factor: 2.279

8.  Comparison of high-power and conventional-power radiofrequency energy deliveries in pulmonary vein isolation using unipolar signal modification as a local endpoint.

Authors:  Koichiro Ejima; Satoshi Higuchi; Kyoichiro Yazaki; Shohei Kataoka; Daigo Yagishita; Miwa Kanai; Morio Shoda; Nobuhisa Hagiwara
Journal:  J Cardiovasc Electrophysiol       Date:  2020-05-15

9.  Safety and efficacy of the ThermoCool SmartTouch SurroundFlow catheter for atrial fibrillation ablation: A meta-analysis.

Authors:  Chao-Feng Chen; Xiao-Fei Gao; Mei-Jun Liu; Chao-Lun Jin; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2019-11-19       Impact factor: 2.882

10.  Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.

Authors:  Chao-Feng Chen; Jing Wu; Chao-Lun Jin; Mei-Jun Liu; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2020-10-27       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.